Ocular Therapeutix grants new hires options for 34,700 shares at $9.66 eachPUBT·Jul 9 at 03:05 PMOCUL-6.00%
Ocular Therapeutix™ Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)Unusual Whales·Jun 22 at 03:08 PMOCUL-6.00%
Ocular Therapeutix grants new SVP inducement awards of 85,000 stock options, 28,000 RSUsPUBT·Jun 22 at 03:05 PMOCUL-6.00%
FDA Alignment on Axpaxli and New CFO Might Change The Case For Investing In Ocular Therapeutix (OCUL)Simplywall·Jun 22 at 10:06 AMOCUL-6.00%
Ocular Therapeutix Maps Regulatory Strategy For Lead Drug Programbenzinga_article·Jun 17 at 09:55 AMOCUL-6.00%
Ocular Therapeutix says FDA aligns on AXPAXLI wet AMD NDA plan for Q4 2026 submissionPUBT·Jun 17 at 07:46 AMOCUL-6.00%
Piper Sandler Keeps Their Buy Rating on Ocular Therapeutix (OCUL)Tip Ranks·Jun 15 at 05:58 AMOCUL-6.00%
